![Pierre Meulien](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pierre Meulien
Direktor/Vorstandsmitglied bei The Innovative Medicines Initiative
Aktive Positionen von Pierre Meulien
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
The Innovative Medicines Initiative
![]() The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Direktor/Vorstandsmitglied | 15.09.2015 | - |
Karriereverlauf von Pierre Meulien
Ehemalige bekannte Positionen von Pierre Meulien
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Genome British Columbia
![]() Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 | 01.01.2010 |
Clinical Research Development Ireland | Gründer | 01.01.2007 | 01.01.2007 |
Präsident | - | 01.01.2007 | |
Ontario Genomics Institute (Private Equity)
![]() Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Corporate Officer/Principal | - | - |
Génome Québec, Inc.
![]() Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Direktor/Vorstandsmitglied | 21.07.2011 | - |
TRANSGENE | Corporate Officer/Principal | 22.06.2011 | - |
Aventis Pasteur Sa | Corporate Officer/Principal | - | - |
Aventis Pasteur Ltd. | Corporate Officer/Principal | - | - |
Genome Canada
![]() Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Direktor/Vorstandsmitglied | 22.06.2011 | - |
Vorstandsvorsitzender | 21.10.2010 | - | |
Präsident | 21.10.2010 | - |
Ausbildung von Pierre Meulien
The University of Liverpool | Undergraduate Degree |
The University of Edinburgh | Doctorate Degree |
Statistik
International
Kanada | 6 |
Frankreich | 3 |
Vereinigtes Königreich | 3 |
Operativ
Corporate Officer/Principal | 4 |
Director/Board Member | 3 |
President | 2 |
Sektoral
Commercial Services | 4 |
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TRANSGENE | Health Technology |
Private Unternehmen | 8 |
---|---|
Aventis Pasteur Sa | Health Technology |
Genome Canada
![]() Genome Canada Miscellaneous Commercial ServicesCommercial Services Genome Canada provides genomic research services. It connects ideas and people across public and private sectors to find new uses for genomics, invests in large-scale science and technology to fuel innovation,and translates discoveries into applications, new technologies, societal impacts and solutions across key sectors of national importance, including health, agriculture, forestry, fisheries and aquaculture, energy, mining, and the environment. The company was founded in 2000 and is headquartered in Ottawa, Canada. | Commercial Services |
Genome British Columbia
![]() Genome British Columbia Miscellaneous Commercial ServicesCommercial Services Genome British Columbia invests in and manages genomics and proteomics research projects. It offers services in human health, environment, agriculture, forestry, mining, energy, aquaculture, and fisheries. The company was founded in 2000 and is headquartered in Vancouver, Canada. | Commercial Services |
Génome Québec, Inc.
![]() Génome Québec, Inc. Miscellaneous Commercial ServicesCommercial Services Génome Québec, Inc. develops genomics and DNA in Quebec. It helps to accelerate the discovery of new applications for genomics and DNA in strategic areas such as human health, forestry and the environment. The company was founded in 2000 and is headquartered in Montreal, Canada. | Commercial Services |
Aventis Pasteur Ltd. | |
Clinical Research Development Ireland | |
The Innovative Medicines Initiative
![]() The Innovative Medicines Initiative Drugstore ChainsRetail Trade The Innovative Medicines Initiative is a public-private partnership that aims to accelerate the development of better and safer medicines for patients. The private company is based in Brussels, Belgium and has subsidiaries in Sweden. The Programme Office, led by the Executive Director, manages the day-to-day operations of the initiative. The initiative recognizes the importance of communication and provides accessible tools generated by their projects to help scientists in their research efforts. The Belgian company was founded by J. Kenneth Charles Knowles. | Retail Trade |
Ontario Genomics Institute (Private Equity)
![]() Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Finance |
- Börse
- Insiders
- Pierre Meulien
- Erfahrung